Shaw G P, Hatt J F, Anderson N G, Hanson P J
Department of Molecular Sciences, Aston University, Birmingham, U.K.
Biochem J. 1987 Jun 15;244(3):699-704. doi: 10.1042/bj2440699.
The site and mechanism of action of epidermal growth factor (EGF) on acid secretion by rat isolated parietal cells were investigated by using the intracellular accumulation of the weak base aminopyrine as an index of secretory activity. When parietal cells were stimulated with histamine (0.5 mM), the concentration of EGF required for half-maximal inhibition of acid secretion was 19 nM, with a maximally effective concentration of EGF producing 38% inhibition of secretory activity. EGF did not inhibit secretion stimulated by 0.1 mM-carbachol, or by 30 microM-, 56 microM-, 100 microM- or 1000 microM-dibutyryl cyclic AMP, low concentrations of which produced a secretory response comparable with that obtained with 0.5 mM-histamine. Addition of 0.1 mM-3-isobutyl-1-methylxanthine (IBMX) substantially increased aminopyrine accumulation in the presence of 0.5 mM-histamine. The inhibitory action of EGF on histamine-stimulated secretion was blocked by 0.1 mM-IBMX, even if low concentrations of histamine were used to generate aminopyrine accumulation ratios similar to those obtained with 0.5 mM-histamine alone. The cyclo-oxygenase inhibitor flurbiprofen (1-100 microM) and the cyclo-oxygenase and lipoxygenase inhibitor nordihydroguaiaretic acid (10-100 microM) did not affect the inhibitory action of EGF. The pattern of inhibition of secretion produced by the activator of Ca2+-sensitive phospholipid-dependent protein kinase, 12-O-tetradecanoylphorbol 13-acetate, was markedly different from that produced by EGF. In conclusion, a major site of the action of EGF on acid secretion in the intact stomach is probably a decrease in the stimulatory effect of histamine by a mechanism which does not involve Ca2+-sensitive phospholipid-dependent protein kinase or the production of prostaglandins, but which might involve enhancement of cyclic AMP phosphodiesterase activity.
以弱碱氨基比林的细胞内蓄积作为分泌活性指标,研究了表皮生长因子(EGF)对大鼠离体壁细胞酸分泌的作用部位和机制。当用组胺(0.5 mM)刺激壁细胞时,半数最大酸分泌抑制所需的EGF浓度为19 nM,最大有效浓度的EGF产生38%的分泌活性抑制。EGF不抑制由0.1 mM卡巴胆碱或30 microM、56 microM、100 microM或1000 microM二丁酰环磷腺苷刺激的分泌,低浓度的这些物质产生的分泌反应与0.5 mM组胺产生的反应相当。添加0.1 mM 3 -异丁基- 1 -甲基黄嘌呤(IBMX)在存在0.5 mM组胺的情况下显著增加了氨基比林的蓄积。即使使用低浓度组胺产生与单独使用0.5 mM组胺相似的氨基比林蓄积率,EGF对组胺刺激分泌的抑制作用也被0.1 mM IBMX阻断。环氧化酶抑制剂氟比洛芬(1 - 100 microM)和环氧化酶及脂氧化酶抑制剂去甲二氢愈创木酸(10 - 100 microM)不影响EGF的抑制作用。钙敏感磷脂依赖性蛋白激酶激活剂12 - O -十四烷酰佛波醇13 -乙酸酯产生的分泌抑制模式与EGF产生的明显不同。总之,EGF在完整胃中对酸分泌作用的主要部位可能是通过一种不涉及钙敏感磷脂依赖性蛋白激酶或前列腺素产生,但可能涉及环磷腺苷磷酸二酯酶活性增强的机制来降低组胺的刺激作用。